Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study.

Published byArron Trevor Bryant Modified over 5 years ago

Similar presentations

Presentation on theme: "Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study."— Presentation transcript:

1 Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using 18F- fluorodeoxyglucose PET/CT  Byung-Soo Kim, MD, PhD, Won-Ku Lee, MD, Kyoungjune Pak, MD, PhD, Junhee Han, PhD, Gun-Wook Kim, MD, Hoon-Soo Kim, MD, PhD, Hyun-Chang Ko, MD, PhD, Moon-Bum Kim, MD, PhD, Seong-Jang Kim, MD, PhD  Journal of the American Academy of Dermatology  Volume 80, Issue 5, Pages (May 2019) DOI: /j.jaad Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Study design. Patients with psoriasis and age-matched, sex-matched healthy controls underwent baseline 18F-FDG PET/CT imaging. Among patients with psoriasis, patients with moderate-to-severe psoriasis were treated with ustekinumab, and 18F-FDG PET/CT images were obtained again after PASI75 was achieved following ustekinumab initiation. 18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography–computed tomography; PASI75, 75% improvement from baseline Psoriasis Area and Severity Index score; PET/CT, positron emission tomography–computed tomography. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Comparison of 18F-FDG uptake between the psoriasis and healthy groups. The 18F-FDG uptake in the psoriasis group (n = 25) and healthy controls (n = 47) is shown. 18F-FDG PET/CT imaging showed increased 18F-FDG uptake in the liver, spleen, and 4 parts of the aorta in patients with psoriasis compared with controls. Bars indicate the mean ± SD values. *Statistically significant (P < .05). 18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography–computed tomography. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Comparison of 18F-FDG uptake among patients in the psoriasis group. A, Comparison of 18F-FDG uptake among patients in the psoriasis group by PASI score. Patients with moderate-to-severe psoriasis (PASI >10) (n = 15) had significantly increased 18F-FDG uptake in the liver, spleen, and all parts of the aorta compared with patients with mild psoriasis (PASI ≤10) (n = 10). B, Comparison of 18F-FDG uptake among patients in the psoriasis group by BMI. The patients with psoriasis who were obese (BMI >25 kg/m2) (n = 11) showed increased 18F-FDG uptake in the liver, spleen, and all parts of the aorta compared with patients with psoriasis who had a normal weight (BMI ≤25 kg/m2) (n = 14). Bars indicate the mean ± SD values. *Statistically significant (P < .05). BMI, Body mass index; 18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography–computed tomography; PASI, Psoriasis Area and Severity Index. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

5 Fig 4 Comparison of 18F-FDG uptake before and after treatment with ustekinumab. Changes in 18F-FDG uptake on PET/CT imaging of the liver, spleen, and arteries after PASI75 was achieved with ustekinumab therapy (n = 25). 18F-FDG uptake was reduced in the liver, spleen, and all parts of the aorta after ustekinumab therapy. Bars indicate the mean ± SD values. *Statistically significant (P < .05). 18F-FDG, 18F-fluorodeoxyglucose; PASI75, 75% improvement from baseline Psoriasis Area and Severity Index score; PET/CT, positron emission tomography–computed tomography. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

6 Fig 5 Ustekinumab-associated changes on the 18F-FDG PET/CT scans. 18F-FDG uptake in the liver (red arrow) and spleen (yellow arrow) was decreased after PASI75 was achieved with ustekinumab treatment: PET (A), CT (B), and PET/CT fusion (C). 18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography–computed tomography; PASI75, 75% improvement from baseline Psoriasis Area and Severity Index score. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study."

Similar presentations

Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),

Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),
Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,

Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,
Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata  Yong Hyun Jang, MD,

Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata  Yong Hyun Jang, MD,
A girl with a solitary red bulla

A girl with a solitary red bulla
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Jenny Dave, MS, Mark A. Ahlman, MD, Benjamin N. Lockshin, MD, David A

Jenny Dave, MS, Mark A. Ahlman, MD, Benjamin N. Lockshin, MD, David A
Aortitis: A new feature of Schnitzler syndrome

Aortitis: A new feature of Schnitzler syndrome
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD 
The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.

The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Efficacy of simvastatin in plaque psoriasis: A pilot study

Efficacy of simvastatin in plaque psoriasis: A pilot study
Expression of PD-L1 in mastocytosis

Expression of PD-L1 in mastocytosis
Treatment of pincer nail deformity using dental correction principles

Treatment of pincer nail deformity using dental correction principles
Remission and time of resolution of nail psoriasis during infliximab therapy  Luca Bianchi, MD, Antonio Bergamin, MD, Catia de Felice, MD, Elisabetta Capriotti,

Remission and time of resolution of nail psoriasis during infliximab therapy  Luca Bianchi, MD, Antonio Bergamin, MD, Catia de Felice, MD, Elisabetta Capriotti,
Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis  Federica Ricceri, MD, Leonardo.

Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis  Federica Ricceri, MD, Leonardo.
Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J
Treatment of nevus depigmentosus using the 308-nm excimer laser: A retrospective study of 14 patients  Jung Min Bae, MD, PhD, Han Mi Jung, MD, Hee Sun.

Treatment of nevus depigmentosus using the 308-nm excimer laser: A retrospective study of 14 patients  Jung Min Bae, MD, PhD, Han Mi Jung, MD, Hee Sun.
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to.

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to.
Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept  Hyunju Jin, MD, Hyun-Ho Cho, MD, Won-Jeong.

Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept  Hyunju Jin, MD, Hyun-Ho Cho, MD, Won-Jeong.

Similar presentations

Ads by Google